Your Current Location : Fund Card : Portfolio Classification |
|
|
|
Kotak Healthcare Fund (G) Direct |
[Equity: Sectoral] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.30 |
Equity |
99.04 |
Trep |
1.26 |
|
|
Concentration Analysis |
Top 5 Holdings |
35.49% |
Top 10 Holdings |
55.48% |
Top 25 Holdings |
94.35% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
82.21 |
Healthcare |
16.83 |
Cash |
0.96 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.70 |
PE Ratio |
34.47 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
14.81 |
Cipla Limited |
7.08 |
DIVI LABORATORIES LTD |
5.23 |
Max Healthcare Institute Limited |
4.19 |
Jubilant Pharmova Limited |
4.18 |
Aurobindo Pharma Limited |
4.16 |
Apollo Hospitals Enterprise Limited |
4.15 |
Dr Reddys Laboratories Limited |
3.93 |
Lupin Limited |
3.88 |
Torrent Pharmaceuticals Limited |
3.87 |
Orchid Pharma Limited |
3.59 |
Alkem Laboratories Limited |
3.42 |
Innova Captab Limited |
3.41 |
J B Chemicals and Pharma Ltd |
3.34 |
Glenmark Pharmaceuticals Limited |
3.13 |
Ajanta Pharma Limited |
2.97 |
Zydus Lifesciences Limited |
2.84 |
Krsnaa Diagnostics Limited |
2.32 |
Ami Organics Limited |
2.19 |
Fortis Health Care Ltd |
2.08 |
Aster DM Healthcare Limited |
2.08 |
Krishna Inst of Medical Sciences Ltd. |
2.01 |
Hikal Limited |
1.97 |
Marksans Pharma Limited |
1.78 |
Emcure Pharmaceuticals Limited |
1.74 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
|
|
|
|
|